Literature DB >> 23187123

A calcium channel mutant mouse model of hypokalemic periodic paralysis.

Fenfen Wu1, Wentao Mi, Erick O Hernández-Ochoa, Dennis K Burns, Yu Fu, Hillery F Gray, Arie F Struyk, Martin F Schneider, Stephen C Cannon.   

Abstract

Hypokalemic periodic paralysis (HypoPP) is a familial skeletal muscle disorder that presents with recurrent episodes of severe weakness lasting hours to days associated with reduced serum potassium (K+). HypoPP is genetically heterogeneous, with missense mutations of a calcium channel (Ca(V)1.1) or a sodium channel (Na(V)1.4) accounting for 60% and 20% of cases, respectively. The mechanistic link between Ca(V)1.1 mutations and the ictal loss of muscle excitability during an attack of weakness in HypoPP is unknown. To address this question, we developed a mouse model for HypoPP with a targeted Ca(V)1.1 R528H mutation. The Ca(V)1.1 R528H mice had a HypoPP phenotype for which low K+ challenge produced a paradoxical depolarization of the resting potential, loss of muscle excitability, and weakness. A vacuolar myopathy with dilated transverse tubules and disruption of the triad junctions impaired Ca2+ release and likely contributed to the mild permanent weakness. Fibers from the Ca(V)1.1 R528H mouse had a small anomalous inward current at the resting potential, similar to our observations in the Na(V)1.4 R669H HypoPP mouse model. This "gating pore current" may be a common mechanism for paradoxical depolarization and susceptibility to HypoPP arising from missense mutations in the S4 voltage sensor of either calcium or sodium channels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23187123      PMCID: PMC3533564          DOI: 10.1172/JCI66091

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.

Authors:  A F Struyk; K A Scoggan; D E Bulman; S C Cannon
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

2.  Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.

Authors:  D Sternberg; T Maisonobe; K Jurkat-Rott; S Nicole; E Launay; D Chauveau; N Tabti; F Lehmann-Horn; B Hainque; B Fontaine
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

3.  A novel sodium channel mutation in a family with hypokalemic periodic paralysis.

Authors:  D E Bulman; K A Scoggan; M D van Oene; M W Nicolle; A F Hahn; L L Tollar; G C Ebers
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

4.  Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle.

Authors:  E Rios; G Brum
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

5.  Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA.

Authors:  T Tanabe; K G Beam; J A Powell; S Numa
Journal:  Nature       Date:  1988-11-10       Impact factor: 49.962

6.  Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current.

Authors:  R L Ruff
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

7.  Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects.

Authors:  T P Links; M J Zwarts; J T Wilmink; W M Molenaar; H J Oosterhuis
Journal:  Brain       Date:  1990-12       Impact factor: 13.501

8.  Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current.

Authors:  K Jurkat-Rott; N Mitrovic; C Hang; A Kouzmekine; P Iaizzo; J Herzog; H Lerche; S Nicole; J Vale-Santos; D Chauveau; B Fontaine; F Lehmann-Horn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

9.  Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters.

Authors:  R Rüdel; F Lehmann-Horn; K Ricker; G Küther
Journal:  Muscle Nerve       Date:  1984-02       Impact factor: 3.217

10.  Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.

Authors:  Robert T Dirksen; Guillermo Avila
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

View more
  42 in total

1.  Leaky channels make weak muscles.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

2.  Phospholemman, a major regulator of skeletal muscle Na+/K+-ATPase, is not mutated in probands with hypokalemic periodic paralysis.

Authors:  Ying-Ying Chen; Xiao-Ying Wang; Qiu-Xia Fu; Yi Kang; He-Bin Yao
Journal:  Exp Ther Med       Date:  2017-07-28       Impact factor: 2.447

3.  Elevated resting H+ current in the R1239H type 1 hypokalaemic periodic paralysis mutated Ca2+ channel.

Authors:  Clarisse Fuster; Jimmy Perrot; Christine Berthier; Vincent Jacquemond; Bruno Allard
Journal:  J Physiol       Date:  2017-09-24       Impact factor: 5.182

Review 4.  When muscle Ca2+ channels carry monovalent cations through gating pores: insights into the pathophysiology of type 1 hypokalaemic periodic paralysis.

Authors:  Bruno Allard; Clarisse Fuster
Journal:  J Physiol       Date:  2018-04-15       Impact factor: 5.182

Review 5.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

Review 6.  Phosphoinositides in Ca(2+) signaling and excitation-contraction coupling in skeletal muscle: an old player and newcomers.

Authors:  Laszlo Csernoch; Vincent Jacquemond
Journal:  J Muscle Res Cell Motil       Date:  2015-09-16       Impact factor: 2.698

Review 7.  Sodium Channelopathies of Skeletal Muscle.

Authors:  Stephen C Cannon
Journal:  Handb Exp Pharmacol       Date:  2018

8.  Impaired calcium signaling in muscle fibers from intercostal and foot skeletal muscle in a cigarette smoke-induced mouse model of COPD.

Authors:  Patrick Robison; Thomas E Sussan; Hegang Chen; Shyam Biswal; Martin F Schneider; Erick O Hernández-Ochoa
Journal:  Muscle Nerve       Date:  2017-02-13       Impact factor: 3.217

9.  A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias.

Authors:  Hong-Gang Wang; Wandi Zhu; Ronald J Kanter; Jonathan R Silva; Christina Honeywell; Robert M Gow; Geoffrey S Pitt
Journal:  J Mol Cell Cardiol       Date:  2016-01-19       Impact factor: 5.000

Review 10.  Skeletal Muscle Channelopathies.

Authors:  Lauren Phillips; Jaya R Trivedi
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.